Introduction: Aortohepatic conduits are a vital option in liver transplantation and more commonly used in pediatric recipients. There is limited information on their long-term outcomes. This study is the largest series to date. Methods: We retrospectively reviewed all consecutive pediatric primary liver transplants performed between 1998 and 2009. Patient demographics, arterial reconstruction technique and the impact on morbidities and survival were studied. The results of aortohepatic conduits were compared with routine anastomosis (arterial revascularization by common hepatic or celiac artery of the recipient) performed in the same time period. Results: Aortohepatic conduits were required in 86/194 (44%) cases. Most common reasons were size (52%) and anatomical incongruities (16%). Grafts used were from the donor iliac arteries (78%), carotids (15%) and thoracic aorta (3%). Inflow was from the recipient infrarenal (95%) and supraceliac aorta (5%). Compared with Routine anastomosis group (N=108), patients with an aortohepatic conduit were younger (47% vs. 26% were < 12 months old, P=0.003), smaller (body weight was ≤6 kg in 27% vs. 10%, P=0.003), more likely to receive technical variant allografts (split/reduced liver or a live donor was used in 42% vs. 19%, P=0.001), and were more often hospital-bound before the transplant (51% vs. 35%, P=0.025). Postoperatively, Aortohepatic conduit group had a higher incidence of prolonged mechanical ventilation (19% vs. 7%, P=0.019) and small bowel obstruction (8% vs. 1%, P=0.023) compared with Routine anastomosis. No increased risk was observed for hepatic artery thrombosis (6% vs. 7%, P=0.66: all cases occurred within 1 month posttransplant), biliary complications (13% vs. 13%, P=0.97), and retransplants (8% vs. 14%, P=0.21). During a median follow-up of 82 months, Aortohepatic conduit group demonstrated a trend toward reduced overall patient survival rate at 5 years compared with Routine anastomosis (80% vs. 89%, respectively, P=0.068: Fig. A). Five-year graft survival was decreased in Aortohepatic conduit group (70% vs. 82%, P=0.047: Fig. B).[Figure]Causes of death and graft loss were similar between 2 groups. Subset analysis revealed that when an aortohepatic conduit was used, graft survival was comparable in recipients < 12 months of age or weighing ≤6 kg, but was diminished in those ≥12 months (65% vs. 84%, P=0.022) or >6 kg (69% vs. 84%, P=0.035). In contrast, graft survival was identical when patients were stratified by the type of the liver allograft (whole liver or technical variant) and pretransplant condition (home or hospital-bound). Conclusions: Aortohepatic conduits for children undergoing primary liver transplants provide a life-saving solution with excellent long-term arterial patency and survival, especially in high-risk recipients such as age < 12 months or body weight ≤6 kg.
Read full abstract